Cargando…

Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed?

Detalles Bibliográficos
Autores principales:	Honore, Patrick M., De Bels, David, Preseau, Thierry, Redant, Sebastien, Spapen, Herbert D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097343/ https://www.ncbi.nlm.nih.gov/pubmed/30115067 http://dx.doi.org/10.1186/s13054-018-2093-y

Ejemplares similares

Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
por: Honore, Patrick M., et al.
Publicado: (2019)

Polymyxin B hemoperfusion in high endotoxin activity level septic shock patients
por: Monti, G, et al.
Publicado: (2008)

Endotoxin removal by hemoperfusion in septic shock
por: Adamik, B, et al.
Publicado: (2011)

Citrate: How to Get Started and What, When, and How to Monitor?
por: Honore, Patrick M., et al.
Publicado: (2018)

Endotoxin removal by polymyxin B: is it a question of dose or duration or both?
por: Honore, Patrick M., et al.
Publicado: (2019)

Adjuvant vitamin C in cardiac arrest patients undergoing renal replacement therapy: an appeal for a higher high-dose
por: Honore, Patrick M., et al.
Publicado: (2018)

ECMO in paediatric septic shock: an urgent need for prospective trial
por: Beretta-Piccoli, Xavier, et al.
Publicado: (2020)

Effective use of polymyxin B hemoperfusion in septic shock complicated by urosepsis
por: Malleshappa, P., et al.
Publicado: (2011)

Clinical benefit of high-volume hemofiltration in severe burn injury: is it removing bad humors or actually avoiding hypervolemia?
por: Honore, Patrick M., et al.
Publicado: (2018)

Anisodamine microcirulatory effects in septic shock: be aware of cardiac side effects
por: Honore, Patrick M., et al.
Publicado: (2021)

Importance of Endotoxin Clearance in Endotoxemic Septic Shock: An Analysis From the Evaluating Use of PolymyxinB Hemoperfusion in a Randomized Controlled Trial of Adults Treated for Endotoxemic Septic Shock (EUPHRATES) Trial
por: Rachoin, Jean-Sebastien, et al.
Publicado: (2020)

Polymyxin B-direct hemoperfusion therapy improves mean arterial pressure in septic shock
por: Yokota, Mari, et al.
Publicado: (2013)

Beneficial effects of early hemoperfusion with a polymyxin B fibre column on septic shock
por: Takeyama, N, et al.
Publicado: (2009)

Polymyxin B Hemoperfusion in Pediatric Septic Shock: Single-Center Observational Case Series
por: Saetang, Patcharin, et al.
Publicado: (2022)

The effect of endotoxin adsorber hemoperfusion on microcirculation in patients with severe sepsis and septic shock
por: Yeh, Y-C, et al.
Publicado: (2015)

Dexmedetomidine: the first new kid on the block for preventing cardiac surgery-associated acute kidney injury?
por: Honore, Patrick M., et al.
Publicado: (2018)

Re-evaluation of direct hemoperfusion with polymyxin-B immobilized fiber for severe sepsis and septic shock
por: Matsuo, SM, et al.
Publicado: (2011)

Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock
por: Kim, Jin Joo, et al.
Publicado: (2019)

Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock
por: Mitaka, Chieko, et al.
Publicado: (2021)

Modifications of peripheral perfusion in patients with vasopressor-dependent septic shock treated with polymyxin B-direct hemoperfusion
por: Sekino, Motohiro, et al.
Publicado: (2023)

278. Effects of polymyxin B direct hemoperfusion by measurement of outer membrane vesicles in patients with septic shock
por: Min Jo, Kyeong
Publicado: (2023)

Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry
por: Cutuli, Salvatore Lucio, et al.
Publicado: (2016)

Extended duration of direct hemoperfusion with polymyxin B-immobilized fiber column improves hemodynamics in patients with septic shock
por: Yamashita, C, et al.
Publicado: (2011)

Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study
por: Nakamura, Yoshihiko, et al.
Publicado: (2017)

Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection
por: Saito, Nobuyuki, et al.
Publicado: (2017)

A successful application of adult polymyxin B-immobilized fiber column hemoperfusion to a neonate with septic shock
por: Kim, Young A, et al.
Publicado: (2019)

Mortality Risk Prediction in Abdominal Septic Shock Treated with Polymyxin-B Hemoperfusion: A Retrospective Cohort Study
por: Garcia-Ramos, Sergio, et al.
Publicado: (2023)

Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
por: Honore, Patrick M., et al.
Publicado: (2021)

Endotoxin activity assay and polymyxin B hemoperfusion use in a cohort of critically ill patients
por: Cutuli, SL, et al.
Publicado: (2014)

Effects of endotoxin adsorber hemoperfusion on sublingual microcirculation in patients with septic shock: a randomized controlled trial
por: Chen, Shih-Hong, et al.
Publicado: (2020)

Polymyxin B-direct hemoperfusion therapy contributes to oxygen delivery in septic patients
por: Yaguchi, A, et al.
Publicado: (2012)

Liquorice Intoxication Can Lead to Cardiac Arrest!
por: Attou, Rachid, et al.
Publicado: (2020)

Polymyxin B-immobilized fiber column hemoperfusion mainly helps to constrict peripheral blood vessels in treatment for septic shock
por: Sugiura, Makiko, et al.
Publicado: (2015)

Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial
por: Payen, Didier M., et al.
Publicado: (2015)

Cost-effectiveness of polymyxin B hemoperfusion for septic shock: an observational study using a Japanese nationwide administrative database
por: Fujimori, Kenji, et al.
Publicado: (2023)

Polymyxin B-immobilized fiber column hemoperfusion has the ability of endotoxin removal during 24 hours
por: Mitaka, C, et al.
Publicado: (2012)

Are SOFA score, PaO(2)/FiO(2) ratio, lymphocytes levels, total bilirubin, lactate dehydrogenase, ferritin, C-reactive protein and interleukin-6 significantly normalized following TPE completion: Is this fact or fiction?
por: Honore, Patrick M., et al.
Publicado: (2021)

Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

Therapeutic Rationale for Endotoxin Removal with Polymyxin B Immobilized Fiber Column (PMX) for Septic Shock
por: Shoji, Hisataka, et al.
Publicado: (2021)

Effectiveness of polymyxin b immobilized fiber hemoperfusion in patients with septic shock due to Gram-negative bacillus infection: the PMXHP study
por: Saito, N, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bni74m1qm674399eel08h437kf